Unique ID issued by UMIN | UMIN000047267 |
---|---|
Receipt number | R000053511 |
Scientific Title | Verification test of body fat reduction effect by ingesting test food |
Date of disclosure of the study information | 2022/06/19 |
Last modified on | 2024/03/22 16:05:23 |
Verification test of body fat reduction effect by ingesting test food
Body fat reduction test by food intake
Verification test of body fat reduction effect by ingesting test food
Body fat reduction test by food intake
Japan |
healthy participants
Adult |
Others
NO
Confirm the effect of reducing body fat by ingesting food.
Efficacy
Body fat 8 weeks,12 weeks after the start of food intake
8, 12 weeks after the start of feeding
Belly fat
Body weight
BMI
Waist circumference
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Treatment
Food |
Ingest foods containing 100 mg of plant-derived extract for 12 weeks
Ingest foods containing 300 mg of plant-derived extract for 12 weeks
Inoculate placebo food for 12 weeks
20 | years-old | <= |
64 | years-old | >= |
Male and Female
(1) Persons with a BMI of 23 kg /m2 or more and less than 30 kg / m2
(2) Obese people with a lot of body fat
(3) Persons who voluntarily consent to participate in the examination by writing
(1) Those who are currently judged to have dyslipidemia or hypertension and are undergoing some kind of treatment.
(2) Ingesting foods and health foods containing the ingredients involved in this test food (plant extract)person
(3) Health foods and dietary supplements related to cholesterol, blood pressure, blood lipids, and blood sugar levelsThose who use it regularly
(4) Glucose metabolism, lipid metabolism, liver disease, renal disease, cardiovascular disease, digestive disease, respiratory disease, blood Persons with serious diseases such as humoral diseases, autoimmune diseases, endocrine diseases, and metabolic diseases.Or a person who has a medical history
(5) Persons with a history of drug allergies or serious food allergies
(6) Persons who have had abnormal laboratory test values and were judged to have problems participating in the study
(7) Persons with illnesses who are currently undergoing hospital visits, treatment, use of medications / external medicines, and follow-up
(8) Those who were judged to be inappropriate as subjects based on the results of the subject background questionnaire.
(9) Those who participated in other clinical studies at the start of this study
(10) Those who are pregnant or plan to breastfeed during the study period
(11) Persons who are judged by the investigator (or the person in charge of conducting the examination) to be inappropriate for participating in the examination
75
1st name | Sumio |
Middle name | |
Last name | Kondo |
Medicial Corporation Kenshokai
Fukushima Healthcare Center
553-0004
Tamagawa 2-12-16, Fukushima-ku, Osaka-shi, Osaka, 553-0004, Japan
06-6441-6848
drc_shokuhin@drc-web.co.jp
1st name | Hiroaki |
Middle name | |
Last name | Furusyo |
DRC Co., Ltd
Food Human Testing Division
530-0044
5F, 9th Tabuchi Building, Higashitenma 2-10-31, Kita-Ku, Osaka city
06-6882-1130
drc_shokuhin@drc-web.co.jp
Medicial Corporation Kenshokai, Fukushima Healthcare Center
Iwase Cosfa Co., Ltd.
Profit organization
Brain Care Clinic Ethics Review Committee
Samon-Cho13, Isobe Build. 2F, Shinjyuku-ku, Tokyo
03-3351-3386
drc_shokuhin@drc-web.co.jp
NO
2022 | Year | 06 | Month | 19 | Day |
Unpublished
Completed
2022 | Year | 02 | Month | 03 | Day |
2022 | Year | 02 | Month | 10 | Day |
2022 | Year | 03 | Month | 07 | Day |
2022 | Year | 06 | Month | 19 | Day |
2022 | Year | 12 | Month | 31 | Day |
2022 | Year | 12 | Month | 31 | Day |
2022 | Year | 12 | Month | 31 | Day |
2022 | Year | 03 | Month | 23 | Day |
2024 | Year | 03 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053511